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Auxin-inducible degron technology allows rapid and con-
trolled protein depletion. However, basal degradation without 
auxin and inefficient auxin-inducible depletion have limited 
its utility. We have identified a potent auxin-inducible degron 
system composed of auxin receptor F-box protein AtAFB2 and 
short degron miniIAA7. The system showed minimal basal 
degradation and enabled rapid auxin-inducible depletion of 
endogenous human transmembrane, cytoplasmic and nuclear 
proteins in 1 h with robust functional phenotypes.
Loss-of-function methods for reducing target protein lev-
els target DNA, RNA or protein1. Auxin-inducible degron (AID) 
technology allows rapid targeted protein depletion with the small-
molecule auxin2. To apply AID, an auxin-inducible destabilizing 
domain, or ‘degron’, is fused to the target protein. In addition, an 
auxin receptor F-box protein TIR1/AFB is exogenously expressed, 
forming a chimeric SKP1-CUL1-F-Box (SCF) ubiquitin E3 ligase 
with endogenous components in eukaryotic cells. The chimeric E3 
ligase recruits the degron in an auxin-dependent manner3. Addition 
of indole-3-acetic acid (IAA) or other small molecules of the auxin 
class to the culture medium thus induces the polyubiquitination 
and rapid proteasomal degradation of the degron-fused protein 
(Fig. 1a). This approach has been used as a powerful tool to acutely 
deplete target proteins in studying their functions4–7. However, cur-
rent AID systems can severely degrade target proteins before IAA 
addition (known as ‘basal degradation’) and suffer from inefficient 
auxin-inducible depletion in a context- and target-specific man-
ner2,8–10. These pitfalls have substantially limited the applications of 
AID technology. An AID system with both minimal basal degrada-
tion and rapid auxin-inducible depletion would be desirable.
In current AID systems, Oryza sativa TIR1 (OsTIR1) is the 
most commonly used auxin receptor F-box protein in combination 
with different degrons deriving from Arabidopsis thaliana IAA17 
(AtIAA17)2,4,5,7–14. We initially aimed to acutely deplete endogenous 
human seipin, a transmembrane protein involved in lipid droplet (LD) 
biogenesis. However, seipin tagged with a degron termed miniAID 
(composed of AtIAA17 amino acid (aa) 68–132) was severely degraded 
in cells expressing OsTIR1 without IAA addition. Consequently, cells 
exhibited defective LD biogenesis already before IAA addition, resem-
bling a seipin knockout phenotype15 (Supplementary Fig. 1a–c).
To search for an improved AID system, we established a pipe-
line in human A431 cells for screening various auxin receptor 
F-box proteins and degrons, through co-integration into the adeno-
associated virus integration site 1 (AAVS1) safe harbor locus16  
(Fig. 1b and Supplementary Note 1). We first compared OsTIR1 
to five other auxin receptor F-box proteins, using miniAID as the 
degron. A. thaliana AFB2 (AtAFB2) was identified as the best 
hit: compared to OsTIR1, it displayed minimal basal depletion 
with over five-fold higher target protein level at 0 h IAA and sim-
ilar auxin-inducible depletion at 16 h IAA treatment (Fig. 1c and 
Supplementary Fig. 2a–e). We speculate that AtAFB2 was superior 
to the other proteins tested probably because of its better thermo-
stability at 37 °C, analogously to OsTIR1 (ref. 2). However, auxin-
inducible depletion with AtAFB2 at 1 h IAA was inefficient. We next 
compared miniAID to 14 other degrons, in combination with either 
AtAFB2 or OsTIR1. All degrons showed severe basal degradation 
at 0 h IAA with OsTIR1 but not with AtAFB2 (Supplementary 
Fig. 3a–c). A degron composed of AtIAA7 amino acids 37–104 
(hereafter denoted ‘miniIAA7’) was identified as an optimal degron 
in combination with AtAFB2. It dramatically improved auxin-induc-
ible depletion with over three-fold more efficient protein reduc-
tion compared to miniAID at 1 h IAA (Fig. 1d and Supplementary 
Fig. 3a–c). Thus, the AtAFB2-miniIAA7 system showed both mini-
mal basal degradation and rapid auxin-inducible depletion.
We tested the AtAFB2-miniIAA7 system for rapidly depleting 
endogenous proteins and revealing acute phenotypes. Dynein heavy 
chain (DHC1) and epidermal growth factor receptor (EGFR) were 
chosen as the first targets. DHC1, a protein essential for cell divi-
sion, suffered from severe basal degradation by using the OsTIR1-
miniAID system in a previous study8. EGFR is a transmembrane 
receptor with a canonical function in EGF uptake that can be acutely 
assessed after protein depletion. Endogenous target loci in human 
cells were tagged with miniIAA7-mEGFP (EGFP, enhanced green 
fluorescent protein) through Cas9-mediated homology-directed 
repair (HDR) (Fig. 1e). We tagged DHC1 homozygously but could 
only tag EGFR heterozygously in A431 cells, likely due to its unusu-
ally high copy number in these cells (data not shown). However, 
we achieved homozygous tagging of EGFR in human A549 cells. 
AtAFB2 or OsTIR1 for comparison, was then introduced into the 
AAVS1 locus of the homozygous knock-in clones. The parental cell 
lines not expressing an auxin receptor F-box protein were used as 
controls (Fig. 1e). We found that both DHC1-AtAFB2 cells (DHC1 
homozygously tagged with miniIAA7-mEGFP and AtAFB2 express-
ing) and EGFR-AtAFB2 cells showed minimal basal degradation at 
0 h IAA, and efficient auxin-inducible depletion at 1 h IAA and at 
longer times (Fig. 1f and Supplementary Fig. 4a). In comparison, 
DHC1-OsTIR1 cells died out during selection, in agreement with 
Natsume et al.8, and EGFR-OsTIR1 cells showed severe basal degra-
dation at 0 h IAA (Fig. 1f and Supplementary Fig. 4a).
We next analyzed whether rapid auxin-inducible depletion 
revealed acute phenotypes. None of the mitotic rounding DHC1-
AtAFB2 cells managed to complete cell division after IAA addition 
for 30 min, while all mitotic rounding cells completed cell divi-
sion without IAA (Fig. 1g and Supplementary Video 1). In EGFR-
AtAFB2 cells, EGF uptake was reduced by about 70% on 1 h IAA 
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treatment, while severe IAA-independent reduction of EGF uptake 
was observed in EGFR-OsTIR1 cells (Fig. 1h). The inducer IAA 
per se did not affect cell division or EGF uptake as shown in the con-
trols (Fig. 1g,h and Supplementary Video 1). Overall, these results 
demonstrate the improved performance of the AtAFB2-miniIAA7 
system in rapidly depleting endogenous proteins and revealing 
acute phenotypes in two human cell types.
In previous experiments, miniIAA7 was used as a C terminal tag 
(Fig. 1b,e). We next tagged miniIAA7 N terminally to an endogenous 
protein. We chose Sec61beta as it is a commonly used target for N 
terminal tagging through HDR. The N terminally tagged Sec61beta 
was efficiently depleted in 1 h with the AtAFB2-miniIAA7 system 
(Supplementary Fig. 4b–e). The tag orientation miniIAA7-mEGFP 
improved auxin-inducible depletion over two-fold at 1 h IAA com-
pared to mEGFP-miniIAA7 (Supplementary Fig. 4b–e). Thus, both 
N and C terminal tagging of miniIAA7 could rapidly deplete target 
proteins when using miniIAA7-mEGFP as a fixed unit.
We then evaluated the overall performance of the AtAFB2-
miniIAA7 system in depleting endogenous proteins. We tagged 
a diverse set of endogenous loci homozygously with miniIAA7-
mEGFP N or C terminally (Fig. 2a) and introduced AtAFB2 or 
OsTIR1 into the AAVS1 locus (as in Fig. 1e). The target proteins 
represented different subcellular localizations and a variable num-





















AAVS1 safe harbor locus





















0 h 0.5 h 1.0 h 13 h


























































































































































EGFR (A549 cells)DHC1 (A431 cells)
0 1 16IAA (h):











Fig. 1 | Identification of AtAFB2-miniIAA7 as an improved AId system. a, Principle of rapid protein depletion with AID. b, Scheme for screening auxin 
receptor F-box proteins and degrons. Target protein levels in cells are analyzed by FACS of GFP at 0 h IAA for basal degradation, at 1 h IAA for early 
depletion efficiency and at 16 h IAA for final depletion efficiency. c,d, Mean GFP intensity analyzed as shown in b. c, miniAID as the degron. Bars represent 
mean ± s.d.; n = 4 biologically independent samples; ctrl, no auxin receptor F-box protein. d, AtAFB2 as the auxin receptor F-box protein. Bars represent 
mean ± s.d.; n = 2 biologically independent samples for miniAID, n = 4 for miniIAA7; ctrl, seipin-mEGFP without degron. e, Scheme for establishing cell 
lines with AtAFB2-miniIAA7 system to deplete endogenous proteins. Control (ctrl) or OsTIR1 were used for comparison. f, Mean GFP intensity analyzed by 
FACS. Bars represent mean ± s.d.; n = 4 biologically independent samples for DHC1, n = 3 for EGFR. N.A., not available due to inability to establish the cell 
line. g, Time-lapse images of DHC1-AtAFB2 cells with or without cell dividing after mitotic cell rounding (left) and analysis of the fraction of cell dividing 
after mitotic rounding (right). Scale bar, 10 μm. On the left: open arrowhead, cells before mitosis; filled arrowhead, cells undergoing mitotic rounding; 
arrow, cells after cell division. On the right, bars represent mean ± s.d.; n = 12 fields. This experiment was repeated once independently with similar results. 
h, Alexa647 EGF uptake analyzed by FACS in EGFR cells. Bars represent mean ± s.d.; paired two-tailed t-test; n = 4 biologically independent samples.
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and a long-lived protein LMNB1 (ref. 17) (Fig. 2b and Supplementary 
Fig. 5a). The expression levels of the target proteins in the established 
cell lines varied by ~50-fold (ranging from 0.19 for seipin to 9.21 for 
LMNA; Fig. 2c). When examining the performance of AtAFB2 with 
these targets in comparison to OsTIR1, we found that all targets had 
minimal basal degradation at 0 h IAA (86–109% levels of controls) 
and were depleted to 2–5% levels at 16 h IAA (Fig. 2d). However, 
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Fig. 2 | depletion of endogenous transmembrane, cytoplasmic and nuclear proteins using the AtAFB2-miniIAA7 system. a, Scheme for N or C terminal 
tagging of endogenous target locus with miniIAA7-mEGFP. b, Illustration of subcellular localization of target proteins. Numbers represent transmembrane 
segments; ER, endoplasmic reticulum; LE, late endosome; N, nucleus; PM, plasma membrane; PX, peroxisome. c, Relative target protein levels analyzed by 
FACS of mean GFP intensity in ctrl cell lines at 0 h IAA. Bars represent mean ± s.d.; n = 3 biologically independent samples, except for Glut1 (n = 4), PEX3 
(n = 4) and LBR (n = 5); a.u., arbitrary unit. d, Mean GFP intensity analyzed by FACS in cells with endogenously miniIAA7-tagged targets and indicated 
auxin receptor F-box proteins or ctrl. Bars represent mean ± s.d.; n = 3 biologically independent samples, except for LBR (n = 4). e, Scheme for increasing 
AtAFB2 nuclear localization (left) and live cell Airyscan images of AtAFB2-mCherry without NLS, with weak or strong NLS in A431 cells (right). This 
experiment was repeated once independently with similar results. Scale bar, 10 μm. f, Mean GFP intensity analyzed by FACS in cells with endogenously 
miniIAA7-tagged proteins and different AtAFB2-mCherry constructs. Bars represent mean ± s.d.; n = 3 biologically independent samples.
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Non-nuclear targets expressed at low levels (seipin, NPC1, PEX3 
and Glut1) were depleted to 2–5%. A non-nuclear target expressed 
at high level (NMIIA) and a target expressed at low level and local-
ized mainly to the inner nuclear envelope (LBR) were also depleted 
to about 10%. Instead, highly expressed nuclear proteins (LMNA 
and LMNB1) were not efficiently depleted (Fig. 2d). In comparison, 
the OsTIR1-miniIAA7 combination resulted in severe basal degra-
dation with all targets at 0 h IAA (12–37%) and unimproved deple-
tion efficiency at 16 h IAA (2–7%) (Fig. 2d).
We continued to improve the depletion of LMNA and LMNB1 
using the AtAFB2-miniIAA7 system. Because AtAFB2 localized 
predominantly to the cytosol (Supplementary Fig. 2c), we increased 
the nuclear localization of AtAFB2-mCherry by fusing nuclear 
localization signals (NLSs) to it (Fig. 2e). Both weak and strong 
NLSs increased the nuclear localization of AtAFB2-mCherry and 
substantially improved auxin-inducible depletion of LMNA and 
LMNB1 at 1 h IAA (Fig. 2e,f). Of note, LBR not restricted to the 
nucleus, as well as Glut1 in the plasma membrane, showed efficient 
auxin-inducible depletion with the weak NLS but not with the strong 
NLS construct (Fig. 2f and Supplementary Fig. 4f). A single dose of 
IAA was sufficient for both non-nuclear and nuclear target deple-
tion for 48 h, and the expression of targets in the degron cells during 
normal culturing was stable (Supplementary Fig. 4g). In summary, 
our results demonstrate that the AtAFB2-miniIAA7 system rapidly 
depleted all selected endogenous transmembrane, cytoplasmic and 
nuclear proteins in 1 h with minimal basal degradation. For rapid 
protein depletion, AtAFB2 needs to be present at sufficient levels in 
the compartment where the target protein resides.
We found that depletion of the endogenous targets with the 
AtAFB2-miniIAA7 system revealed robust and expected pheno-
types as early as 1 h after IAA addition, depending on the functional 
readouts. These included reduced glucose uptake in Glut1 degron 
cells (cells with AtAFB2-miniIAA7 system targeting Glut1), clear 
changes of F-actin structures in NMIIA degron cells, accumulation 
of cholesterol in late endosomal compartments in NPC1 degron 
cells, LD biogenesis defects in seipin degron cells, reduction of 
cellular cholesterol levels in LBR degron cells and extensive deg-
radation of peroxisomal membrane proteins in PEX3 degron cells 
(Supplementary Fig. 5b–g).
MiniIAA7-mEGFP worked well for rapid inducible depletion in 
all the cases tested, but we also explored whether mEGFP can be 
omitted or substituted by other tags. We found that for seipin, C 
terminal miniIAA7 alone worked at a compromised efficiency and 
this could be improved by attaching mCherry, mScarlet-I (ref. 18) or 
a small 3XFlag tag to its C terminus (Supplementary Fig. 6a,b). We 
envision that mEGFP or other extensions to the C terminus of mini-
IAA7 may help to avoid steric hindrance during auxin-inducible 
binding and/or serve as an additional SCFAtAFB2 E3 ligase substrate.
In comparison to the recently reported dTAG system19 
(Supplementary Fig. 7a), the improved AID system may have some 
advantages. By employing AtAFB2 overexpression, the AID system 
is effective in different cell lines and subcellular compartments and 
for rapidly degrading proteins of high and low abundance. The 
dTAG system relies on the activity of endogenous cereblon (CRBN) 
and might be more host cell sensitive, as suggested by its low effi-
ciency in A431 cells (Supplementary Figs. 7b,c and 8a,b). Moreover, 
rapid degradation of highly abundant proteins might be challeng-
ing with the dTAG system, as judged by the slower degradation of 
LMNA (Supplementary Fig. 8a,b).
Finally, protein degradation induced with the AtAFB2-miniIAA7 
system was more readily reversible on IAA washout than with the 
OsTIR1-miniIAA7 system (Supplementary Fig. 9a,b). The improved 
AID system also appeared better than the dTAG system in washout 
experiments (Supplementary Figs. 7d and 9c), potentially because 
it employs a coreceptor strategy for IAA binding20 compared to the 
heterobifunctional binding of dTAG19 (Supplementary Fig. 9d). 
Besides human cells, the AID technology has been applied in other 
organisms such as yeast2,4, Caenorhabditis elegans12, Drosophila13 
and mouse embryos11. We believe that the AtAFB2-miniIAA7 sys-
tem can also improve the performance of AID in these applications.
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Methods
Cell culture. A431 cells (ATCC, cat. no. CRL-1555) and HEK293A cells 
(Invitrogen, R70507) were cultured in DMEM (Lonza), and A549 cells (ATCC, 
cat. no. CCL-185) in F-12 Nutrient Mixture (Gibco), supplemented with 10% 
FBS, penicillin/streptomycin (100 U ml−1 each), l‐glutamine (2 mM) at 37 °C in 
5% CO2. Mycoplasma testing was performed regularly using PCR detection. Cells 
were transfected at 80–95% confluence using Lipofectamine LTX with PLUS 
Reagent (Life Technologies), typically with 1.0 µg plasmid(s) per 1.0 µl of PLUS 
reagent (1.5 µl for HEK293A), 2.0 µl of Lipofectamine LTX (3.0 µl for HEK293A) 
and 4.0 × 105 (A431 and HEK293A) or 3.0 × 105 (A549) cells in a 12-well. Indole-
3-acetic acid sodium (IAA, Santa Cruz, sc-215171) was prepared at 100× in H2O 
(10 mg ml−1), aliquoted, stored at −20 °C and used within 2 d after thawing.
Construction of vectors for AAVS1 site-specific integration. AAVS1 safe 
harbor locus site-specific integration was conducted with CRISPR/Cas9-
mediated HDR. A donor vector was generated by assembling PCR amplified 
fragments by restriction digestion and ligation. The resulting vector contained 
two homology arms (from A431 genomic DNA) flanking an overexpression 
cassette with puromycin selection marker (from pEFIRES-P21) on a plasmid 
backbone (from pGL3-basic). This donor vector was designated as pSH-
EFIRES-P and used to express different auxin receptor F-box proteins. A second 
donor vector was generated by changing the puromycin selection marker 
on the first vector with blasticidin selection marker. This donor vector was 
designated as pSH-EFIRES-B and used to express seipin-mEGFP with different 
degrons. A third vector co-expressing Cas9 and a single guide RNA (sgRNA) 
(both derived from PX458, Addgene no. 48138, ref. 22) was designated as 
pCas9-sgRNA. The vector was inserted with two sgRNAs targeting AAVS1 safe 
harbor locus (sgAAVS1-1 target sequence: ACCCCACAGTGGGGCCACTA 
GGG; sgAAVS1-2 target sequence: GTCACCAATCCTGTCCCTAG TGG). 
Auxin receptor F-box proteins, except OsTIR1 (Addgene no. 72835)8, and 
degron tags were codon-optimized and synthesized by Genscript (sequences 
in Supplementary Table 1). Auxin receptor F-box proteins were tagged with 
mCherry through overlap PCR using a 5 aa linker GGSGG. The two NLSs for 
AtAFB2-mCherry were weak NLS (MycA1, AAAKRVKLD) and strong NLS 
(Myc, PAAKRVKLD). The three vectors with insertions and their full sequences 
will be deposited in Addgene.
Generation of A431 cell pools for screening. A431 cell pools were generated 
to stably express different combinations of auxin receptor F-box protein and 
degron-fused seipin through co-integration into the AAVS1 safe harbor locus. Cells 
were cotransfected with a mixture of three vectors composed of pSH-EFIRES-P 
expressing an auxin receptor F-box protein, pSH-EFIRES-B expressing a degron-
fused seipin and pCas9-sgAAVS1 at ratio of 3:3:4. Transfected cells were passaged 
4–6 h after transfection at 1:5 into six-well plates. The next day, cells were selected 
with 1 µg ml−1 puromycin (Sigma, P8833) for 2 d, and with 5 µg ml−1 blasticidin 
(Gibco, A1113904) for 2 d, then with both antibiotics for at least 6 d before using 
for fluorescence-activated cell sorting (FACS) analysis.
FACS analysis. Cells were seeded at 1:5 (for A431) or 1:3 (for A549) into a six-well 
plate in medium without selection on day 0. On day 1, the medium was changed 
to 2 ml fresh medium without (for 0 h and 1 h IAA samples) or with (for 16 h IAA 
samples) 0.5 mM IAA. On day 2, the 1 h samples were supplemented with 0.5 ml 
medium containing 2.5 mM IAA (final 0.5 mM) and incubated for 1 h at 37 °C. 
After treatment, cells were detached with 0.5 ml trypsin at 37 °C for 5–8 min 
(A549) or 8–12 min (A431), put on ice and transferred to 1.5 ml Eppendorf 
tubes containing 0.5 ml serum-free CO2 independent medium (Gibco). The cell 
suspensions were centrifuged at 4 °C, resuspended in 0.3 ml ice-cold serum-free 
FluoroBrite DMEM (Gibco) and stored on ice before FACS analysis. FACS analysis 
was performed on a BD Influx cell sorter (BD Biosciences) with a 100 µm nozzle 
at 4–8 °C using BD FACS Sortware. Cells were gated with SSC, FSC and trigger 
pulse width for singlets, and 100,000 cells were analyzed from each sample. GFP 
was excited with a 488 nm laser and detected with a 530/40 detector; mCherry 
was excited with a 561 nm laser and detected with a 615/20 detector. Data were 
analyzed with BD FACS Sortware. Background subtracted mean fluorescence 
intensity was used for analysis.
Construction of vectors for endogenous tagging. Degron tagging of endogenous 
loci was conducted with CRISPR–Cas9-mediated HDR. Donor vectors with two 
homology arms flanking the degron tag, and Cas9 vectors with specific sgRNAs 
were constructed for each target. For constructing donor vectors, homology 
arms were amplified from A431 genomic DNA. MiniIAA7-mEGFP tags were 
amplified from established templates in the screens above and miniAID tag (used 
in Supplementary Fig. 1) was amplified from Addgene no. 72825 (ref. 8). Overlap 
PCR was then performed to assemble PCR fragments. Nested PCR primers were 
used to improve the PCR efficiency and specificity. All PCR amplification steps 
were performed with Q5 Hot Start High-Fidelity DNA Polymerase (NEB). The 
PCR fragments were cloned into plasmid backbones using HiFi DNA assembly kit 
(NEB) or through restriction ligation. Some of the donor vectors were generated 
by changing the inserts on the established donor vectors through restriction 
ligation. For constructing Cas9 vectors, target sites were searched manually for 
–NGG PAM sequence within 18 base pairs after insertion sites or CCN- PAM 
within 18 bp before insertion sites. These position restraints were set for both 
high-efficiency integration and for avoiding further mutations after successful 
HDR. The DHC1 target sites were selected at the 3′ untranslated region, as no 
target site was available in the searching range. A pCas9/QRVR-sgRNA23 vector 
was later constructed through PCR mutagenesis of pCas9-sgRNA to enable use 
of target sites with –NGA (or TCN-) PAM in the searching range. SgRNAs were 
synthesized as two unphosphorylated primers, annealed and inserted into BbsI-cut 
pCas9-sgRNA or pCas9/VRQR-sgRNA vector. Information about endogenous 
targets, HDR templates, primers for HDR templates and sgRNAs is provided in 
Supplementary Table 1.
Generation of homozygously tagged cell lines. HDR pools were first generated, 
followed by FACS enrichment of high GFP expressing cells and limiting dilution 
in 96-well plates to obtain single clones. Single clones were screened first by 
fluorescence microscopy for proper GFP expression and subcellular localization, 
then by genomic PCR to check for homozygous tagging. A detailed protocol 
is described below. A431 or A549 cells in 12-well plates were first transfected 
with a donor vector (0.6 µg) plus a Cas9/sgRNA vector encoding puromycin 
resistance gene (0.4 µg). After 4–6 h, cells were passaged into 10 cm dishes. 
The next day, medium was changed to 1 µg ml−1 puromycin for 2 d, then to 
normal medium without puromycin. This procedure eliminated efficiently 
untransfected cells without selecting for stable puromycin resistant cells. After 
culturing in normal medium for 4 d, the cells were passaged to fresh medium 
for 2 d and the resulting cells were considered the HDR pools. For each target, 
we typically tried 2–3 sgRNAs in duplicate, and the relative HDR efficiencies in 
the pools were assessed by fluorescence microscopy. HDR pools with the highest 
efficiency were used for FACS analysis as above, and cells with the highest 1–5% 
GFP intensity were gated for sorting. The sorted cells were used for single clone 
isolation with limiting dilution in 96-well plates. For each pool, 10–20 clones 
were isolated, from which 2–3 clones were picked with fluorescent microscopy 
for high GFP signal and proper subcellular localization. These clones were 
further tested for homozygous tagging using genomic PCR, with typically two 
single clones finally selected for each target. The best sgRNAs, their efficiency 
in HDR pools analyzed by FACS and primers for genomic PCR are listed in 
Supplementary Table 1.
Generation of degron cell lines. Homozygously tagged single clones were used 
to generate degron cells overexpressing an auxin receptor F-box protein. Auxin 
receptor F-box proteins were introduced into the AAVS1 safe harbor loci of single 
clones through Cas9-mediated HDR. Cells were transfected with 0.4 µg pCas9-
sgAAVS1 and 0.6 µg pSH-EFIRES-P plasmid encoding an auxin receptor F-box 
protein. Transfected cells were passaged at 1:5 after 4–6 h. The next day, cells were 
selected with 1 µg ml−1 puromycin for 6 d before passaging for experiments or 
further culturing. The resulting cell pools were used for FACS analysis and loss-
of-function studies without single cloning. Then, 5 µg ml−1 of puromycin was used 
occasionally to improve the expression level of the auxin receptor F-box proteins 
in the A431 pools. FACS sorting was performed to enrich A549-EGFR pools 
responsive to IAA treatment. For this, A549 pools were treated with 1 h IAA and 
sorted for cells with low GFP.
Live cell Airyscan imaging. Cells cultured in FluoroBrite DMEM with 10% FBS in 
eight-well Lab-Tek II no. 1.5 coverglass slides (Thermofisher) were imaged with a 
Zeiss LSM 880 equipped with an Airyscan detector using a ×63 Plan-apochromat 
oil objective with a numerical aperture of 1.4. Live cell imaging was performed 
at 37 °C, 5% CO2 with incubator insert PM S1. Images were Airyscan processed 
automatically using the Zeiss ZEN2 software package.
Analysis of cell division in A431 cells with tagged DHC1. Cells were plated 
on μ-slide eight-well ibiTreat dishes at 0.1 × 105 cells per well 2 d before the 
experiment. On the experiment day, cells were loaded with 2 µM CellTracker 
Red CMTPX (Thermo, cat. no. C34552) in complete medium for 15–30 min at 
37 °C. Medium was then changed to FluroBrite DMEM containing 10% FBS and 
incubated at 37 °C for 1–2 h before imaging to equilibrate the label. Cells were 
imaged with Nikon Eclipse Ti-E microscope equipped with ×20 air objective, 
numerical aperture of 0.8, Nikon Perfect Focus System 3, Hamamatsu Flash 4.0 
v.2 scientific complementary metal-oxide-semiconductor and Okolab stage top 
incubator system. Before recording, six fields for each of the eight wells were 
selected with CellTracker Red fluorescence. IAA was then added at a final 0.5 mM 
concentration to IAA-treated samples, mixed well with pipetting and time-lapse 
imaging started immediately recording every 30 min for 16 h. Mitotic rounding 
cells were counted manually in the videos from 0.5 h to 6 h. Mitotic rounding cells 
without cell division were followed until 13 h had elapsed.
EGF uptake in A549 cells with tagged EGFR. A549 cells were seeded at 0.4 × 105 
cells per four wells for 3 d. Medium was changed to fresh medium with or without 
0.5 mM IAA for 1 h. Cells were washed twice with ice-cold serum-free medium 
with 1% BSA, and 0.2 ml of 2 µg ml−1 Alexa Fluor 647 EGF complex (ThermoFisher, 
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E35351) in serum-free medium with 1% BSA was added. Cells were further 
incubated at 37 °C for 20 min before collecting with trypsin. Samples were kept 
on ice before FACS analysis. Alexa Fluor 647 was excited with 640 nm laser and 
detected with 720/40 detector, analyzing 20,000 cells per sample. Negative control 
samples were cells incubated in medium without EGF complex. Background 
subtracted mean fluorescence intensity was used for analysis.
Glucose uptake in A431 cells with tagged Glut1. Cells were plated at 0.6 × 105 
cells on four-well plates 2 d before the experiment. On the experiment day, cells 
were treated with or without 0.5 mM IAA for 1 h at 37 °C, then washed with DPBS 
(Gibco, 14040117 with calcium and magnesium). Glucose uptake was measured 
by incubating cells with 1 mM 2-deoxyglucose in DPBS for 10 min at room 
temperature and subsequent steps were performed according to the manufacturer’s 
protocol (Promega, cat. no. J1341). Luminescent signal was measured in a 
96 black well microplate (SCREENSTAR, cat. no. 655866) with VICTOR X3 
multimode plate reader (PerkinElmer). Cells incubated with DPBS only were 
used as background. Protein concentrations were measured with Bio-Rad DC 
assay. Glucose uptake after background subtraction was normalized to protein 
concentration.
F-actin staining in A431 cells with tagged NMIIa. Cells were plated at 0.3 × 105 on 
μ-slide eight-well ibiTreat chambers 1 d before the experiment. On the experiment 
day, cells were treated with or without 0.5 mM IAA for 2 h at 37 °C, then washed 
with PBS, fixed with 4% PFA in 250 mM HEPES, pH 7.4, 100 μM CaCl2 and 100 μM 
MgCl2 for 20 min, followed by quenching in 50 mM NH4Cl for 10 min and three 
washes with PBS. Cells were then stained with 0.132 µM Alexa Fluor 568 Phalloidin 
(Molecular probes A-12380) in PBS for 30 min at room temperature. Z-stacks 
spanning the whole cell (step size 0.3 μm) were acquired with Nikon Eclipse Ti-E 
microscope, 60X PlanApo VC oil objective with a numerical aperture of 1.4 and a 
×1.5 zoom. Image stacks were automatically deconvolved using the Huygens batch 
processing application (Scientific Volume Imaging), and deconvolved image stacks 
were maximum intensity projected in ImageJ FIJI.
Filipin staining in A431 cells with tagged NPC1. Cells on coverslips in complete 
medium were treated with or without 0.5 mM IAA for 16 h, fixed and quenched 
as above. Fixed cells were then stained with 50 µg ml−1 of filipin in PBS for 30 min 
at 37 °C. Cells were washed twice with PBS and mounted with mowiol-DABCO. 
Imaging was performed on a Nikon Eclipse Ti-E microscope equipped with ×100 
oil objective with a numerical aperture of 1.4.
LD biogenesis in A431 cells with tagged seipin. Cells were delipidated by 
culturing in serum‐free medium supplemented with 5% lipoprotein-deficient 
serum for 3 d and treated with or without 0.5 mM IAA for the final 16 h on μ-slide 
eight-well ibiTreat slides. For LD biogenesis, cells were loaded with 0.2 mM oleic 
acid (oleic acid prepared as a 1 mM OA-BSA complex at a 10:1 molar ratio to BSA 
in serum-free DMEM) for the final 2 h, fixed and quenched as above. LDs were 
stained with LD540 (synthesized by Princeton BioMolecular Research, 0.1 µg ml−1) 
and nuclei with DAPI (Sigma, D9542, 10 μg ml−1). Z-stacks spanning the whole cell 
(step size 0.3 μm) were acquired with Nikon Eclipse Ti-E microscope, ×60 PlanApo 
VC oil objective with a numerical aperture of 1.4 and a ×1.5 zoom lens, and 
image stacks were automatically deconvolved using the Huygens batch processing 
application (Scientific Volume Imaging), then deconvolved image stacks maximum 
intensity projected by custom MATLAB scripts. Cell segmentation, LD detection 
and LD size distribution analysis was performed with CellProfiler24 and custom 
MATLAB software was generated for post-processing.
Cholesterol measurement in A431 cells with tagged LBR. Cells were delipidated 
by culturing in serum‐free medium supplemented with 5% lipoprotein-deficient 
serum for 3 d and treated with or without 0.5 mM IAA for the final 48 h. Cells 
were washed, gathered with ice-cold PBS and cell pellets were used for analysis. 
Cholesterol was measured by gas–liquid chromatography analysis. The chloroform-
methanol extracts of cellular lipids were saponified with potassium hydroxide 
in ethanol, extracted with hexane and silylated with trichloromethylsilane. 
Cholesterol was separated from noncholesterol sterols and squalene and quantified 
by capillary gas–liquid chromatography with flame ionization detection and using 
a 50‐m capillary column (Ultra 2, Agilent Technologies) with 5α‐cholestane as the 
internal standard as described25. Protein concentration was measured from aliquots 
of the same samples with a Bio-Rad DC Protein assay.
Western blotting. Cells were lyzed in buffer containing 1.0% Igepal CA-630, 0.5% 
sodium deoxycholate, 0.1% sodium dodecyl sulfate, 250 mM Tris-HCl, pH 7.5 
and 150 mM NaCl with protease inhibitors. Samples in 1× Laemmli buffer were 
incubated at 37 °C for 0.5–2 h before loading. Equal amounts of protein (measured 
using DC Protein assay) were loaded onto 7.5–12% TGX Stain-Free gels, activated 
after running and transferred onto LF PVDF membrane (Bio-Rad). Images 
of Stain-Free total protein staining were acquired after transferring to PVDF 
membrane. Membranes were blotted with Odyssey blocking buffer (LI-COR) at 
room temperature for 0.5–1.0 h, incubated with first antibody (rabbit anti-GFP, 
Abcam ab290; mouse anti-alpha Tubulin, Sigma B-5-1-2; mouse anti-EGFR, DSHB 
CPTC-EGFR-1; mouse anti-PMP70, Sigma SAB4200181; rabbit anti-seipin, in-
house-generated antibody against C terminal region of human seipin; mouse anti-
HA, Sigma H9658) at 4 °C overnight or at room temperature for 2 h. Detection was 
performed with IRDye 800CW goat anti-mouse (Li-cor 926-32210) and Alexa 680 
goat anti-rabbit antibodies (Invitrogen A21109) and all images were acquired with 
a ChemiDoc MP Imaging System (Bio-Rad).
Analysis of PMP22-mCardinal fluorescence in A431 cells with tagged PEX3. 
Cells were transfected with mCardinal-PMP-N-10 (Addgene no. 56173, a gift from 
M. Davidson)26. Single clones with low mCardinal-PMP-N-10 expression and 
proper subcellular localization were isolated after FACS sorting of low mCardinal 
fluorescent cells. Cells were treated with or without 0.5 mM IAA for 14 d and 
seeded on μ-slide eight-well ibiTreat chambers for the final 2 d. Cells were fixed 
and quenched as above. Nuclei were stained with DAPI (Sigma, D9542, 10 μg ml−1). 
Z-stacks spanning the whole cell (step size 0.3 μm) were acquired with Nikon 
Eclipse Ti-E microscope, ×60 PlanApo VC oil objective with a numerical aperture 
of 1.4 and a ×1.5 zoom lens. Maximum intensity projections were generated in FIJI 
and cells segmented in CellProfiler. Background subtracted PMP22-mCardinal 
fluorescence intensity was analyzed from the segmented images using a custom 
MATLAB software generated for post-processing.
Testing different miniIAA7 tags. For testing of different miniIAA7 tags, a 
single A431 cell clone stably overexpressing AtAFB2-mCherry was first isolated. 
Constructs overexpressing seipin with different miniIAA7 fusion tags were 
generated through PCR and restriction ligation (mScarlet-I from pLifeAct_
mScarlet-i_N1, Addgene no. 85056, ref. 18). These constructs were introduced 
into the AAVS1 safe harbor locus of AtAFB2-mCherry overexpressing cell clone 
through CRISPR–Cas9-mediated HDR as described above. After selection, 
stable cell pools were used for experiments. The full sequences and the plasmids 
encoding miniIAA7-mCherry, miniIAA7-mScarlet-I and miniIAA7-3XFlag will be 
deposited in Addgene.
Testing the dTAG system. Endogenous BRD4 in HEK293A and A431 cells 
was tagged N terminally with FKBP (F36V) through CRISPR–Cas9-mediated 
Precise Integration into Target Chromosome (PITCh) as reported19. Briefly, 
cells in 12-wells were transfected with 0.6 µg of template pCRIS-PITChv2-
BSD-dTAG (BRD4) (Addgene no. 91792) plus 0.4 µg of sgRNAs/Cas9 plasmid 
pX330A-nBRD4/PITCh (Addgene no. 91794) with Lipofectamine LTX. At 
4–6 h post-transfection, cells were passaged to 25 cm2 dishes for 2 d. Cells 
were further passaged to 60 cm2 dishes and selected with 10 µg ml−1 blasticidin 
(Gibco, A1113904) for 6 d before passaging for experiments or further culturing. 
Endogenous LMNA in cells was tagged N terminally with FKBP (F36V) through 
CRISPR–Cas9-mediated HDR. MiniIAA7-mEGFP tag in LMNA HDR template 
was substituted through restriction ligation with Puro-P2A-2XHA-FKBP (F36V) 
tag (from pCRIS-PITChv2-Puro-dTAG (BRD4), Addgene no. 91793). Cell pools 
were generated by transfection with 0.6 µg of template plus 0.4 µg of pCas9-
sgLMNA. Transfected cells were passaged and selected as above, except using 
2 µg ml−1 puromycin for selection. The bifunctional degrader dTAG-13 (TOCRIS, 
6605) was prepared as 20 mM stock in DMSO (21 mg ml−1), aliquoted and stored 
at −20 °C. The stock was further diluted with DMSO so that for all treatments, 
DMSO was used at 0.02% final concentration.
HDR coselection of LMNA degron cell pools. Cells with endogenously  
tagged LMNA were coselected by selecting cells with AtAFB2-mCherry- 
weak NLS integration into AAVS1 locus, as both happen through HDR27.  
Cells in a 12-well were transfected with three plasmids, pCas9/sgLMNA/ 
sgAAVS1, LMNA HDR template plasmid and AtAFB2-mCherry-weak NLS in 
pSH-EFIRES-P at a ratio of 4:4.5:1.5. Cells were passaged to a 60 cm2 dish at  
4–5 h post-transfection and selected with 2 µg ml−1 puromycin starting on  
the next day for 2 d, followed by 5 µg ml−1 puromycin for 4 d. The resulting cell 
pools were used for experiments.
Reversibility assays. For washout experiments, cells were seeded at day 1. Cells 
were treated with 0.5 mM IAA or 0.1 µM dTAG-13 (Supplementary Fig. 9a–c) or 
0.5 µM dTAG-13 (Supplementary Fig. 7d) for 16 h at different time points, washed 
with complete medium twice and further cultured for indicated periods before 
collection at day 4 for FACS or western blot analysis.
Statistics and reproducibility. Graphpad Prism 7.04 (Graphpad Software, Inc.) 
was used to generate graphs, perform t-tests and calculate P values. Quantitative 
data are presented as mean ± s.d., if not otherwise stated. The raw data underlying 
the graphical representations are provided in the Source data. Typically, two cell 
lines were used for endogenous targets. All immunoblots are representatives of two 
independent experiments. The uncropped scans of all immunoblots shown are 
provided in Supplementary Fig. 10.
Reporting Summary. Further information on research design is available in the 
Nature Research Reporting Summary linked to this article.
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data availability
The data that support the findings of this study are available from the 
corresponding author upon reasonable request.
Code availability
Custom software scripts (to be used with CellProfiler and MATLAB in 
Supplementary Fig. 5e,g) can be found at https://bitbucket.org/szkabel/
lipidanalyser/get/master.zip.
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Reporting Summary
Nature Research wishes to improve the reproducibility of the work that we publish. This form provides structure for consistency and transparency 
in reporting. For further information on Nature Research policies, see Authors & Referees and the Editorial Policy Checklist.
Statistics
For all statistical analyses, confirm that the following items are present in the figure legend, table legend, main text, or Methods section.
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement
A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one- or two-sided 
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested
A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons
A full description of the statistical parameters including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) 
AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 
Give P values as exact values whenever suitable.
For Bayesian analysis, information on the choice of priors and Markov chain Monte Carlo settings
For hierarchical and complex designs, identification of the appropriate level for tests and full reporting of outcomes
Estimates of effect sizes (e.g. Cohen's d, Pearson's r), indicating how they were calculated
Our web collection on statistics for biologists contains articles on many of the points above.
Software and code
Policy information about availability of computer code
Data collection BD FACS Sortware for FACS data. 
Zeiss ZEN2 software package for Airyscan images. 
NIS-Elements Advanced Research with 6D image acquisition module for wildfield images and videos.
Data analysis BD FACS Sortware for processing and analyzing FACS data. 
Zeiss ZEN2 software package for processing Airyscan images. 
CellProfiler 1.0.5122 and MATLAB R2017a for processing and analyzing lipid droplet distribution (Supplementary Fig 5e) and 
PMP22-mCardinal fluorescence (Supplementary Fig 5g) with custom software scripts available at  https://bitbucket.org/szkabel/
lipidanalyser/get/master.zip. 
Graphpad Prism 7.04 for graphs and statistical analysis. 
All softwares above are available freely or commercially.
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers. 
We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
Data
Policy information about availability of data
All manuscripts must include a data availability statement. This statement should provide the following information, where applicable: 
- Accession codes, unique identifiers, or web links for publicly available datasets 
- A list of figures that have associated raw data 
- A description of any restrictions on data availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
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Life sciences Behavioural & social sciences  Ecological, evolutionary & environmental sciences
For a reference copy of the document with all sections, see nature.com/documents/nr-reporting-summary-flat.pdf
Life sciences study design
All studies must disclose on these points even when the disclosure is negative.
Sample size No statistical method was used to predetermine sample size. Multiple targets were used for the test. Typically 2 cell lines were used for each 
endogenous target. Experiments were repeated independently as least once. For FACS experiments, each data point was obtained from tens 
of thousands of cells.
Data exclusions No data were excluded from analysis.
Replication Replication was successful in all cases. Experiments were repeated independently at least once. Results with endogenous targets were 
consistent between different cell lines. Conclusions were consistent with all targets.
Randomization No randomization was performed.
Blinding Blinding did not apply as all experiments were done in cell culture and did not involve animal or human research participants. 
Reporting for specific materials, systems and methods
We require information from authors about some types of materials, experimental systems and methods used in many studies. Here, indicate whether each material, 
system or method listed is relevant to your study. If you are not sure if a list item applies to your research, read the appropriate section before selecting a response. 
Materials & experimental systems













Antibodies used Rabbit anti-GFP: Abcam ab290 (1:5,000) 
Mouse anti-alpha Tubulin: Sigma B-5-1-2 (1:10,000) 
Mouse anti-EGFR: DSHB CPTC-EGFR-1 (0.5-1.0 μg/ml) 
Mouse anti-PMP70: Sigma SAB4200181 (1:1,000) 
Rabbit anti-seipin: in-house-generated antibody against C-terminal region of human seipin (1:400) 
Mouse anti-HA: Sigma H9658 (1:5,000) 
IRDye 800CW goat anti-mouse: Li-cor 926-32210 (1:10,000) 
Alexa 680 goat anti-rabbit: Invitrogen A21109 (1:10,000).
Validation Rabbit anti-GFP Abcam ab290 : tag antibody validated for WB; see manufacturer’s website and validated in this study.  
Mouse anti-HA Sigma H9658: tag antibody validated for WB; see manufacturer’s website and validated in this study.  
Mouse anti-alpha Tubulin Sigma B-5-1-2: validated for WB in human samples, see manufacturer’s website.  
Mouse anti-EGFR DSHB CPTC-EGFR-1: validated for WB in human samples ; see manufacturer’s website and validated in this 
study.  
Mouse anti-PMP70 Sigma SAB4200181: validated for WB in human samples, see manufacturer’s website. 
Rabbit anti-seipin in-house-generated antibody against C-terminal region of human seipin: validated for WB of overexpressed 
human seipin in this study.  
IRDye 800CW goat anti-mouse and Alexa 680 goat anti-rabbit: secondary antibodies validated for WB by the see manufacturer’s 
and in this study.
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Policy information about cell lines
Cell line source(s) A431 cells (ATCC, Cat#CRL-1555); A549 cells (ATCC, Cat#CCL-185); HEK293A cells (Invitrogen, R70507).
Authentication A431 cells, A549 cells and HEK293A cells were confirmed with visual inspection of the morphologies of the cells (compared to 
pictures provided by the vendors). A431 cells were also confirmed with unusually high level of EGFR expression through 
tagging with miniIAA7-mEGFP tag (over 2-fold higher GFP level compared to LMNA in heterozygously tagged cell lines) and 
through western blot with anti-EGFR antibody. No further authentication was performed for the three cell lines.
Mycoplasma contamination The cells were tested for mycoplasma contamination with PCR and the results were negative.
Commonly misidentified lines
(See ICLAC register)




The axis labels state the marker and fluorochrome used (e.g. CD4-FITC).
The axis scales are clearly visible. Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of identical markers).
All plots are contour plots with outliers or pseudocolor plots.
A numerical value for number of cells or percentage (with statistics) is provided.
Methodology
Sample preparation Single-cell suspensions were stored on ice prior to analysis. Cells were filtered  through a 35 μm nylon mesh before reading them 
in the Flow Cytometer.
Instrument BD Influx cell sorter (BD Biosciences-US) 
Software BD FACS™ Sortware
Cell population abundance Single cloning to obtain homozygously tagged cell lines post sorting was successful.
Gating strategy Cells were gated with SSC, FSC for cells, and trigger pulse width for singlets.
Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.
